RxDoctor Payments Data

Amarpal Gill

Nurse Practitioner · Bakersfield, CANPI 1801565551

Payments from drug & device makers

$4,569in general payments, 2019–2025

Across 176 payments — averaging $25.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$993
  • AstraZeneca$911
  • Boehringer Ingelheim$662
  • Regeneron Healthcare Solutions, Inc.$546
  • Verona Pharma, Inc.$286
  • Amgen$245
  • plus $925 from 15 others

What the payments were for

  • Food & beverage$4,31094%
  • Education$2596%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,569 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OfevNintedanib Esylate19$256,146
Trelegy ElliptaFluticasone/Umeclidin/Vilanter255$163,856
Breo ElliptaFluticasone/Vilanterol106$47,600
Breztri AerosphereBudesonide/Glycopyr/Formoterol58$38,369
Spiriva RespimatTiotropium Bromide19$15,817
Albuterol Sulfate HfaAlbuterol Sulfate437$11,261
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$9,723
Arnuity ElliptaFluticasone Furoate41$8,528
Fluconazole26$6,581
Azelastine Hcl184$4,110
Incruse ElliptaUmeclidinium Bromide11$3,761
BreynaBudesonide/Formoterol Fumarate14$3,554
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$3,168
Fluticasone Propionate336$3,063
Qvar RedihalerBeclomethasone Dipropionate12$2,855

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimOfev, Spiriva Respimat$662$271,96338 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta$993$233,468432 claims
AstraZenecaBreztri Aerosphere$911$38,36958 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Bakersfield

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →